ARTICLE
TITLE

Yes, breast cancer related lymphoedema can be managed

SUMMARY

AbstractThe purpose of the study was to demonstrate that breast cancer related lymphoedema can be managed by means of Complete Decompression Therapy and consequently improve quality of life. An instrumental case study design was used. The target population was all women with breast cancer related lymphoedema living in Tshwane, the context of the study. The patient with the most severe breast cancer related lymphoedema treated by the researcher is presented. Mixed methods were used to gather data. The expected 60% limb volume reduction could not be achieved after 4 weeks of induction therapy. After 8.5 weeks of treatment, the limb volume reduced from the initial 3841 mL to 1639 mL, a 57.2% reduction. Patient compliance to compression therapy was a challenge and led to relapse extending the induction phase of treatment. Despite the prolonged treatment, the limb volume reduction improved the patient’s quality of life. The study demonstrated and confirmed that despite a degree of noncompliance, breast cancer related lymphoedema can be managed with Complete Decongestive Therapy which, in turn, improves the quality of life of women living with breast cancer.OpsommingDie doelstelling van die studie was om te demonstreer dat borskanker-verwante limfedeem deur middel van Volledige Dekompressie Terapie beheer kan word wat gevolglik die pasiënt se lewenskwaliteit verbeter. ‘n Instrumentele gevallestudie-ontwerp is gevolg. Die populasie waaruit die geval gekies is, het uit alle vroue met borskanker-verwante limfedeem in Tshwane, die konteks van die studie, bestaan. Die pasiënt met die ergste limfedeem wat die navorser behandel het, word voorgedra. Gekombineerde metode is ingespan om data in te samel. Die verwagte 60% vermindering in die armedeem binne 4 weke van induksie behandeling is nie bereik nie. Na 8.5 weke van behandeling het die edeem van die oorspronklike 3841 mL tot 1639 mL verminder wat ‘n 57.2% reduksie verteenwoordig. Die pasiënt het nie die voorskrifte ten opsigte van dekompressie terapie noukeurig nagekom nie, wat terugvalling en ‘n verlengde induksie-fase tot gevolg gehad het. Die vermindering van die armedeem het die pasiënt se lewenskwaliteit nogtans positief beïnvloed. Die studie het aangetoon dat, ten spyte van pasiënt afvalligheid, dit moontlik was om borskanker-verwante limfedeem deur middel van Volledige Dekompressie Terapie te verminder en lewenskwaliteit te verbeter.

 Articles related

Giske Ursin, Samera A. Qureshi    

We describe mammographic density and how it is associated with breast cancer risk, what mammographic density represents biologically, as well as evidence that it is associated with breast cancer risk factors and is modifiable. Mammographic density has a ... see more


Astri Syse, Marijke Veenstra, Bjarte Aagnes, Steinar Tretli    

Background: Cancer is a disease closely associated with aging. Aging populations will thus lead to a pronounced increase in the absolute number of elderly persons with cancer, resulting in profound public health challenges in the coming decades. Older pa... see more


J G Mthembu,MMZU Bhuiyan    

Down syndrome is a genetic condition characterised by the presence of all or part of an extra chromosome 21 and is linked to a spectrum of medical and phenotypic features. Chromosome 21 is associated with tumour suppressor gene expression. Individuals wi... see more


Franja Dugar, Katja Goricar, Vita Dolžan, Tanja Marinko    

Breast cancer is a heterogeneous disease that can be treated by surgery, systemic therapy, and radiotherapy. Adjuvant breast cancer radiotherapy has important implications for patient survival but also causes adverse events. During radiation, not only ca... see more


Marika Freus,Agnieszka Kolasa,Barbara Wiszniewska    

Introduction: Breast cancer is one of the most common malignancies in women and is relatively rare in men (12% vs. 0.1%). The effect of sex hormones on the risk and development of cancer among transgender people is not fully understood, although it is we... see more